Xiaoding Xu

7.8k total citations · 3 hit papers
118 papers, 6.5k citations indexed

About

Xiaoding Xu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xiaoding Xu has authored 118 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 29 papers in Biomedical Engineering and 26 papers in Biomaterials. Recurrent topics in Xiaoding Xu's work include RNA Interference and Gene Delivery (38 papers), Nanoplatforms for cancer theranostics (25 papers) and Advanced biosensing and bioanalysis techniques (22 papers). Xiaoding Xu is often cited by papers focused on RNA Interference and Gene Delivery (38 papers), Nanoplatforms for cancer theranostics (25 papers) and Advanced biosensing and bioanalysis techniques (22 papers). Xiaoding Xu collaborates with scholars based in China, United States and Saudi Arabia. Xiaoding Xu's co-authors include Phei Er Saw, Omid C. Farokhzad, Jacob A. Moulijn, Jinjun Shi, Wei Tao, Xian‐Zheng Zhang, Xiaoyuan Ji, Ren‐Xi Zhuo, J.J.F. Schölten and Si‐Xue Cheng and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Xiaoding Xu

115 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy

2017 488 citations Wei Tao, Xiaoyuan Ji et al. Angewandte Chemie International Edition profile →
ROS‐Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy

2017 431 citations Xiaoding Xu, Phei Er Saw et al. profile →
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output

2020 337 citations Xiaoding Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoding Xu China	42	2.9k	2.3k	1.7k	1.5k	998	118	6.5k
Qi Lei China	50	2.4k 0.8×	4.6k 2.0×	2.5k 1.5×	3.8k 2.5×	510 0.5×	144	8.8k
Jianbin Tang China	42	2.4k 0.8×	3.1k 1.3×	2.4k 1.5×	1.4k 0.9×	216 0.2×	142	6.8k
Bingyang Shi China	48	3.1k 1.1×	3.3k 1.4×	2.0k 1.2×	3.2k 2.1×	517 0.5×	140	9.1k
Chunlei Zhang China	49	2.0k 0.7×	4.7k 2.0×	1.7k 1.0×	4.6k 3.0×	375 0.4×	181	8.9k
Guannan Wang China	43	2.0k 0.7×	1.2k 0.5×	782 0.5×	2.3k 1.5×	233 0.2×	228	6.3k
Dokyoon Kim South Korea	42	1.5k 0.5×	4.1k 1.8×	1.8k 1.1×	4.1k 2.7×	256 0.3×	74	8.3k
Xiuli Hu China	41	1.3k 0.5×	3.0k 1.3×	3.0k 1.8×	2.0k 1.3×	163 0.2×	129	6.7k
Lu Gan China	47	3.3k 1.1×	2.4k 1.0×	1.3k 0.8×	1.3k 0.8×	1.2k 1.2×	182	7.0k
Jingjing Liu China	31	1.4k 0.5×	3.4k 1.4×	1.3k 0.8×	2.3k 1.5×	286 0.3×	114	5.6k
Zhibo Liu China	43	1.9k 0.7×	1.2k 0.5×	356 0.2×	1.2k 0.8×	539 0.5×	179	6.7k

Countries citing papers authored by Xiaoding Xu

Since Specialization

Citations

This map shows the geographic impact of Xiaoding Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoding Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoding Xu more than expected).

Fields of papers citing papers by Xiaoding Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoding Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoding Xu. The network helps show where Xiaoding Xu may publish in the future.

Co-authorship network of co-authors of Xiaoding Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoding Xu. A scholar is included among the top collaborators of Xiaoding Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoding Xu. Xiaoding Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Zixuan, et al.. (2024). Nanoparticles (NPs)-mediated targeted regulation of redox homeostasis for effective cancer therapy. SHILAP Revista de lepidopterología. 5(2). 291–320. 16 indexed citations

Huang, Zixian, Chunfang Wei, Yi Chen, et al.. (2024). Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy. Acta Biomaterialia. 193. 429–439. 6 indexed citations

Lü, Nan, et al.. (2024). LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway. Journal of Experimental & Clinical Cancer Research. 43(1). 267–267. 5 indexed citations

Li, Lin, Yuan Cao, Rui Xu, et al.. (2024). Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment. Advanced Healthcare Materials. 13(26). e2401436–e2401436. 3 indexed citations

Xu, Rui, Weirong Li, Chunhao Lin, et al.. (2023). Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy. Acta Biomaterialia. 162. 98–109. 20 indexed citations

Liu, Xiaodi, Qi Zhang, Yanni Xu, et al.. (2023). Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy. Acta Pharmaceutica Sinica B. 13(12). 5048–5059. 8 indexed citations

Xu, Xiaoding, Xiangyu Pan, Ai‐Jun Hou, et al.. (2023). MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism. iScience. 26(11). 108352–108352. 3 indexed citations

Li, Senlin, Ziqi Huang, Chunfang Wei, et al.. (2023). Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib. Advanced Science. 10(19). e2207118–e2207118. 27 indexed citations

Hu, Huijun, et al.. (2023). The Critical Shoulder Angle Can be Accurately and Reliably Determined from Three‐Dimensional Computed Tomography Images. Orthopaedic Surgery. 15(8). 2052–2061. 3 indexed citations

10.

Xu, Lei, Rui Xu, Phei Er Saw, et al.. (2021). Nanoparticle-Mediated Inhibition of Mitochondrial Glutaminolysis to Amplify Oxidative Stress for Combination Cancer Therapy. Nano Letters. 21(18). 7569–7578. 59 indexed citations

11.

Zheng, Guoliang, Liang Zhao, Jia Li, et al.. (2021). A genetically encoded fluorescent biosensor for monitoring ATP in living cells with heterobifunctional aptamers. Biosensors and Bioelectronics. 198. 113827–113827. 30 indexed citations

12.

Li, Yujing, Jianxun Ding, Xiaoding Xu, et al.. (2020). Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Letters. 20(7). 4857–4863. 50 indexed citations

13.

Saw, Phei Er, Xiaoding Xu, Meng Zhang, et al.. (2020). Nanostructure Engineering by Simple Tuning of Lipid Combinations. Angewandte Chemie. 132(15). 6308–6311. 2 indexed citations

14.

Xie, Jing, et al.. (2020). Long Noncoding RNA CAR10 Contributes to Melanoma Progression By Suppressing miR-125b-5p to Induce RAB3D Expression. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Saw, Phei Er, Xiaoding Xu, Meng Zhang, et al.. (2020). Nanostructure Engineering by Simple Tuning of Lipid Combinations. Angewandte Chemie International Edition. 59(15). 6249–6252. 25 indexed citations

16.

Nie, Yan, Hongyan Huang, Mingyan Guo, et al.. (2019). Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy. Clinical Cancer Research. 25(13). 3873–3886. 128 indexed citations

17.

Saw, Phei Er, Herui Yao, Chunhao Lin, et al.. (2019). Stimuli-Responsive Polymer–Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy. Nano Letters. 19(9). 5967–5974. 115 indexed citations

18.

Zhu, Xianbing, Xiaoyuan Ji, Na Kong, et al.. (2018). Intracellular Mechanistic Understanding of 2D MoS₂ Nanosheets for Anti-Exocytosis-Enhanced Synergistic Cancer Therapy. ACS Nano. 12(3). 2922–2938. 194 indexed citations

19.

Tao, Wei, Xiaoyuan Ji, Xiaoding Xu, et al.. (2017). Antimonene Quantum Dots: Synthesis and Application as Near‐Infrared Photothermal Agents for Effective Cancer Therapy. Angewandte Chemie. 129(39). 12058–12062. 97 indexed citations

20.

Xu, Xiaoding, Phei Er Saw, Wei Tao, et al.. (2017). Tumor Microenvironment-Responsive Multistaged Nanoplatform for Systemic RNAi and Cancer Therapy. Nano Letters. 17(7). 4427–4435. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact